| Santa Barbara Senior Care | |
|
6167 Covington Way Goleta CA 93117-1740 | |
| (805) 451-2709 | |
| Not Available |
| Full Name | Santa Barbara Senior Care |
|---|---|
| Speciality | Internal Medicine |
| Location | 6167 Covington Way, Goleta, California |
| Authorized Official Name and Position | Anne V White (PRESIDENT) |
| Authorized Official Contact | 8054512709 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Santa Barbara Senior Care 6167 Covington Way Goleta CA 93117-1740 Ph: (805) 451-2709 | Santa Barbara Senior Care 6167 Covington Way Goleta CA 93117-1740 Ph: (805) 451-2709 |
| NPI Number | 1699542563 |
|---|---|
| Provider Enumeration Date | 12/11/2023 |
| Last Update Date | 01/25/2024 |
| Medicare PECOS PAC ID | 8527411503 |
|---|---|
| Medicare Enrollment ID | O20240125002877 |
News Archive
Cancer is a complex disease and only thanks to advances in genomic techniques have researchers begun to understand, at a cellular and molecular level, the mechanisms which are disrupted in cancer cells. This knowledge is a key prerequisite for developing effective treatment strategies.
A new tuberculosis (TB) drug regimen designed to improve options for TB therapy eliminated more bacteria from sputum than standard therapy and did so at a faster rate, according to data from a phase 2b clinical trial published today in The Lancet. These results are published just as the global phase 3 clinical trial, designed to bring this regimen through the last stage of testing, has begun.
A computerized tool to help emergency room physicians determine whether a patient is having a heart attack may not work as well among some racial and ethnic groups, according to research of almost 12,000 patients at nine medical centers.
The use of nanoparticles — small, virus-sized elements developed under laboratory conditions — is increasingly widespread in the world of biomedicine. This rapidly-evolving technology offers hope for many medical applications, whether for diagnosis or therapies.
Scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine (WSU SOM) in Detroit will present the world's largest study that shows the long-term results of fast neutron radiotherapy (FNRT) in the treatment of localized prostate cancer. The findings will be formally announced Tuesday, Nov. 2, at the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699542563 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | (* (Not Available)) | Primary |
| Provider Name | Anne V White |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1801809660 PECOS PAC ID: 7416055074 Enrollment ID: I20070605000264 |
News Archive
Cancer is a complex disease and only thanks to advances in genomic techniques have researchers begun to understand, at a cellular and molecular level, the mechanisms which are disrupted in cancer cells. This knowledge is a key prerequisite for developing effective treatment strategies.
A new tuberculosis (TB) drug regimen designed to improve options for TB therapy eliminated more bacteria from sputum than standard therapy and did so at a faster rate, according to data from a phase 2b clinical trial published today in The Lancet. These results are published just as the global phase 3 clinical trial, designed to bring this regimen through the last stage of testing, has begun.
A computerized tool to help emergency room physicians determine whether a patient is having a heart attack may not work as well among some racial and ethnic groups, according to research of almost 12,000 patients at nine medical centers.
The use of nanoparticles — small, virus-sized elements developed under laboratory conditions — is increasingly widespread in the world of biomedicine. This rapidly-evolving technology offers hope for many medical applications, whether for diagnosis or therapies.
Scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine (WSU SOM) in Detroit will present the world's largest study that shows the long-term results of fast neutron radiotherapy (FNRT) in the treatment of localized prostate cancer. The findings will be formally announced Tuesday, Nov. 2, at the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting
› Verified 4 days ago
News Archive
Cancer is a complex disease and only thanks to advances in genomic techniques have researchers begun to understand, at a cellular and molecular level, the mechanisms which are disrupted in cancer cells. This knowledge is a key prerequisite for developing effective treatment strategies.
A new tuberculosis (TB) drug regimen designed to improve options for TB therapy eliminated more bacteria from sputum than standard therapy and did so at a faster rate, according to data from a phase 2b clinical trial published today in The Lancet. These results are published just as the global phase 3 clinical trial, designed to bring this regimen through the last stage of testing, has begun.
A computerized tool to help emergency room physicians determine whether a patient is having a heart attack may not work as well among some racial and ethnic groups, according to research of almost 12,000 patients at nine medical centers.
The use of nanoparticles — small, virus-sized elements developed under laboratory conditions — is increasingly widespread in the world of biomedicine. This rapidly-evolving technology offers hope for many medical applications, whether for diagnosis or therapies.
Scientists from the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine (WSU SOM) in Detroit will present the world's largest study that shows the long-term results of fast neutron radiotherapy (FNRT) in the treatment of localized prostate cancer. The findings will be formally announced Tuesday, Nov. 2, at the American Society of Therapeutic Radiology and Oncology (ASTRO) Annual Meeting
› Verified 4 days ago
Rite Aid Pharmacy Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 199 N Fairview Ave, Goleta, CA 93117 Phone: 805-964-9892 | |
Goleta Neighborhood Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 334 S Patterson Ave, Suite 203, Goleta, CA 93111 Phone: 805-617-7878 Fax: 805-617-7880 | |
Hope Refuge Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2504 Refugio Rd, Goleta, CA 93117 Phone: 310-343-8108 | |
The Medcenter, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 271 N Fairview Ave Ste 101, Goleta, CA 93117 Phone: 805-681-7411 Fax: 805-681-7410 | |
Goleta Neighborhood Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 5580 Calle Real, Goleta, CA 93111 Phone: 805-617-7878 Fax: 805-617-7880 | |
Goleta Neighborhood Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 334 S Patterson Ave, Suite 203, Goleta, CA 93111 Phone: 805-617-7878 Fax: 805-617-7880 |